Breathe Well Live Well
|
Delaying asthma care can have serious results
OnMedica People who delay presenting for emergency asthma care may have worse outcomes than those who seek help sooner, and be more likely to require admission, researchers have found. They told the American Thoracic Society 2011 International Conference in … ATS: Many Parents of Children With Asthma Avoid Flu Vaccine |
View full post on asthma – Google News
|
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results
PR Newswire (press release) Palatin has started discussions with a number of potential development and marketing partners for PL-3994 for acute asthma, which would include the proof-of-concept human trial for asthma using a subcutaneously administered formulation and development … Palatin Technologies CEO Discusses F3Q2011 Results – Earnings Call Transcript |
View full post on asthma – Google News
|
Palatin Technologies CEO Discusses F3Q2011 Results – Earnings Call Transcript
Seeking Alpha On the next program, I would like to talk about is PL-3994, our natriuretic peptide receptor agonist in development as a treatment for acute exacerbations of asthma. Acute exacerbations of asthma, also called acute severe asthma, is an ongoing asthma … Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2011 Results |
View full post on asthma – Google News
|
MediciNova Reports Fourth Quarter and Full Year 2010 Results
TradersHuddle.com The decrease in research and development expenses primarily related to the completion of the clinical trial evaluating MN-221 at planned escalating doses in patients with severe acute exacerbations of asthma treated in emergency departments in 2009 and … |
View full post on asthma – Google News
|
Critical Therapeutics Inc. Reports Operating Results (10-K)
GuruFocus.com Asthma is a chronic respiratory disease characterized by the narrowing of the lung airways, making breathing difficult. An asthma attack leaves the victim short of breath as the airways become constricted and inflamed. The National Center for Health … Cornerstone Therapeutics 4Q profit falls on expenses, but results top Wall … |
View full post on asthma – Google News
 Stockopedia |
Verona Pharma Receives Positive Results For Asthma Treatment At Higher Doses
Daily Markets By Stockopedia on February 22, 2011 | More Posts By Stockopedia | Author's Website Verona Pharma (LON:VRP) , the AIM listed biotech company with a focus on developing treatments for chronic respiratory diseases such as asthma, has completed a … Verona Pharma announces positive results from mild asthma study |
View full post on asthma – Google News
|
Verona Pharma announces positive results from mild asthma study
Trading Markets (press release) Verona Pharma plc, a biotechnology company, has completed a successful trial of higher doses of its lead respiratory drug, RPL554, in patients with mild asthma. The randomized, blinded trial, with placebo control, took place in Leiden, The Netherlands, … |
View full post on asthma – Google News
|
UCLA releases results of new asthma study
Examiner.com Almost 5 million Californians have been diagnosed with asthma. On December 16, 2010, the UCLA Center for Health Policy Research released the results of a … |
View full post on asthma – Google News
 Our Health Care Source |
Health Care Collaboration Produces Real Results for Children with Asthma
Our Health Care Source The CareSource Foundation recently awarded a signature grant of $75000 to the Ohio chapter of the AAP supporting an asthma quality improvement initiative. … |
View full post on asthma – Google News
|
MediciNova Reports Third Quarter 2010 Results
MarketWatch (press release) The presentations are related to MediciNova's development of MN-221 for potential utility in acute exacerbations of asthma or chronic obstructive pulmonary … |
View full post on asthma – Google News